SECOND SIGHT MEDICAL PRODUCTS INC

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

FY: Dec 31 2021

FY: Dec 31 2021

Regulation FD Disclosure

Regulation FD Disclosure

Results of Operations and Financial Condition

Regulation FD Disclosure

Regulation FD Disclosure

Entry into a Material Definitive Agreement

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Regulation FD Disclosure

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Regulation FD Disclosure

Other Events

Regulation FD Disclosure

Other Events

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Notice of Effectiveness

Prospectus Supplement for Primary Offering

Written communication about a business combination transaction (Rule 425)

Registration statement under Securities Act of 1933 (amendment)

Written communication about a business combination transaction (Rule 425)

Registration statement under Securities Act of 1933

Written communication about a business combination transaction (Rule 425)

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Required Information in Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Required Information in Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

No description available

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

No description available

Porter Lisa Ellen

Baldor Anthony

Le Truc

Mendelsohn Adam

Dwyer Donald

BRADBURY DANIEL

Williams Gregg

Moretti August J

Moretti August J

Popoff Alexandra L.

Mendelsohn Aaron

BRADBURY DANIEL

Williams Gregg

Williams Gregg

Williams Gregg

Williams Gregg

Williams Gregg

Williams Gregg

Williams Gregg

Williams Gregg

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

Correspondence with the SEC

Letter from the SEC

Annual Report Scanned (Paper)

Annual Report Scanned (Paper) (amendment)

Annual Report Scanned (Paper)

Notification of the removal from listing and registration of matured redeemed or retired securities

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Definitive information statement

Correspondence with the SEC

Letter from the SEC

No description available

Correspondence with the SEC

Correspondence with the SEC